The review argues that psychosocial factors and psychiatric comorbidity (especially anxiety and depression) are intrinsic to FD aetiopathogenesis, not merely drivers of consultation behaviour . The authors marshal three evidence tiers: (1) epidemiology β six population-based studies showed higher psychological morbidity in FD vs non-dyspeptic controls; (2) temporality β Koloski's 12-year cohort found baseline anxiety predicted later dyspepsia, while FD did not predict later anxiety; GP records showed psychological disorder preceded dyspepsia in 61% vs 34% converse cases; (3) mechanism β H215O-PET data showing failed perigenual ACC activation and impaired descending modulatory connectivity (pACCβamygdalaβPAG) during gastric distension, with anxiety correlating inversely with pACC activity . Psychosocial factors explained 30% of variance in gastric discomfort threshold β a substantial, mechanistically anchored effect.
The authors explicitly acknowledge cross-sectional designs dominate, precluding causal inference, and that screening questionnaires rather than structured psychiatric interviews were used in most studies. Unaddressed blind spots: no imaging study adjusted brain activity for anxiety/depression (a confound the authors flag); HPA-axis studies did not stratify by abuse history; the peripheral-vs-central dichotomy persists despite their integrated model. Treatment evidence is weak β a 2005 Cochrane review found only four small, methodologically flawed psychotherapy trials .
A 2024 Pakistani cross-sectional cohort (n=222 EGD patients) reports strikingly high comorbidity β anxiety 57.8%, depression 65.8% β with anxiety associated with NERD/ORDS and depression with GERD and dyspepsia subgroups β consistent with the review's thesis, but hospital-based selection inflates estimates. Conversely, an Italian IBS cohort found FD overlap amplified psychopathology (SCL-90-R GSI higher in IBS+FD, n=26, vs IBS-only, n=56) , suggesting psychiatric burden scales with symptom-network complexity β compatible with the review but hinting that somatization (not anxiety per se) may be the stronger driver, as Van Oudenhove's own symptom-severity data implied.
A high-quality, conceptually influential review whose central claim β FD as a disorder of brain-gut signalling with intrinsic psychosocial contribution β is moderately supported but causally underdetermined. It would be falsified by longitudinal cohorts showing FD symptoms predicting later anxiety/depression equivalently in both directions, or by imaging studies demonstrating brain-activity abnormalities persisting after anxiety/depression adjustment. Notably, the review itself flags this missing control β a mark of scientific candor.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.